Suraksha Diagnostics’ shares open to a lukewarm response: ending over 5% down on debut
Suraksha Diagnostics’ stock opened at ₹437 and ₹438 on the BSE & NSE respectively, slipping 0.90% & 0.68% respectively below…
Suraksha Diagnostics’ stock opened at ₹437 and ₹438 on the BSE & NSE respectively, slipping 0.90% & 0.68% respectively below…
India is on track to solidify its position as a key player in the global medical technology (MedTech) market, with…
The United Healthcare CEO Brian Thompson’s murder was meticulously planned, but the suspect’s actions and movements were notably careless, according…
Kanpur: As part of a government initiative, 35 doctors, staff, and health officers on December 5, 2024 adopted 51 tuberculosis…
Johns Hopkins University (JHU) has partnered with the Ajit Isaac Foundation (AIF) to launch a state-of-the-art 63-bed palliative care hospital…
Dr. Lal Path Labs: In this comprehensive report on Dr. Lal Path Labs possibly expanding into Southern India in near…
New Delhi: Petitioners addressing India’s severe air pollution crisis submitted a plea to Parliament on December 5, 2024 according to…
Bhopal: In a landmark move to promote transparency and protect patient rights, the Chief Medical and Health Officer (CMHO) of…
FDA (The U.S. Food and Drug Administration) has granted accelerated approval to Merus N.V.’s bispecific antibody, Bizengri (zenocutuzumab-zbco), for the…
Recently, John Hopkins University and the Ajit Isaac Foundation have entered into a Memorandum of Understanding (MoU) to establish a…